Consolidated Financial Results
for the Nine Months Ended March 31, 2022
[Japanese GAAP]
April 28, 2022
Company name: OLBA HEALTHCARE HOLDINGS, Inc.
Stock exchange listing: Tokyo Stock Exchange
Code number: 2689
URL: https://www.olba.co.jp/
Representative: Yohei Maeshima, President CEO
Contact: Nobuharu Murata, Managing Director and General Manager, Administrative Department
Phone: +81-86-236-1115
Scheduled date of filing quarterly securities report: May 13, 2022
Scheduled date of commencing dividend payments: Availability of supplementary briefing material on quarterly financial results: UnavailableSchedule of quarterly financial results briefing session: Not scheduled(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Nine Months Ended March 31, 2022 (July 1, 2021 toMarch 31, 2022)(1) Consolidated Operating Results(% indicates changes from the previous year.)
Net income
Net sales
Operating income
Ordinary income
attributable toowners of parent
Nine months ended
Million yen%
Million yen%
Million yen%
Million yen%March 31, 2022
81,756
5.3
1,678
23.7
1,701
25.0
1,133
28.3
March 31, 2021
77,608–
1,356
69.7
1,360
74.0
883
92.3
(Note) Comprehensive income: Nine months ended March 31, 2022: ¥1,092 million [25.2%]
Nine months ended March 31, 2021: ¥872 million [121.2%]
Basic earnings
per share

Diluted earnings
per share

Nine months ended
YenYenMarch 31, 2022
186.29–March 31, 2021
145.30–(Note) Effective the beginning of the fiscal year ending June 30, 2022, the Company began applying the AccountingStandard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020) and other standards. In accordancewith the principle-based treatment of the standards, the consolidated operating results for the fiscal year ended
June 30, 2021 have been restated retroactively. The change in net sales for the nine months ended March 31, 2021
are, therefore, not presented.
(2) Consolidated Financial Position
Total assets

Net assets

Million yen

42,377
As of March 31, 2022
As of June 30, 2021
36,562(Reference) Equity: As of March 31, 2022: ¥8,888 million
As of June 30, 2021: ¥8,131 million

Equity ratio

Million yen%

8,888
8,131

21.0
22.2

2. Dividends
Annual dividends
1stquarter-end
Fiscal year ended June 30, 2021
Fiscal year ending June 30, 2022
Fiscal year ending June 30, 2022(Forecast)

2ndquarter-end

3rdquarter-end

YenYen

Yen

Yen

Yen––

0.00
0.00

––

50.00

50.00

60.00

60.00

Year-end

Total(Note) Revision to the forecast for dividends announced most recently: Yes

3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 2022 (July 1, 2021 to June 30, 2022)(% indicates changes from the previous corresponding period.)
Net sales
Million yen%Operating incomeOrdinary income

Million yen

Million yen%

Net income
attributable toowners of parent% Million yen

Basic earnings
per share%

Yen

Full year
107,500 5.3
2,000 29.8
2,030 31.6
1,460 47.6
240.04(Note) Revision to the financial results forecast announced most recently: Yes(Note) Effective the beginning of the fiscal year ending June 30, 2022, the Company began applying the AccountingStandard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020) and other standards. Those standards
have been reflected in the figures of the consolidated financial results forecast above. The changes in net sales
from the previous corresponding periods have been calculated by retroactively applying those standards to thefigures for the fiscal year ended June 30, 2021.
Notes:(1) Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting inchanges in scope of consolidation): None
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name)(2) Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: None
(3) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: Yes
2) Changes in accounting policies other than 1) above: None
3) Changes in accounting estimates: None
4) Retrospective restatement: None
(4) Total number of issued shares (common stock)1) Total number of issued shares at the end of the period (including treasury stock):
March 31, 2022: 6,250,000 shares
June 30, 2021: 6,250,000 shares2) Total number of treasury stock at the end of the period:
March 31, 2022: 163,476 shares
June 30, 2021: 167,676 shares
3) Average number of shares during the period:
Nine months ended March 31, 2022: 6,085,264 shares
Nine months ended March 31, 2021: 6,082,381 shares
As of March 31, 2022, 112,400 shares of the Company’s stock held by the Board Benefit Trust were included intreasury stock.

* Quarterly financial results are outside the scope of the quarterly review procedures conducted by a certified public
accountant or audit corporation.
* Explanation of the proper use of financial results forecast and other notes
The figures forecasted above are based on information that is available as of the date of publication of thisdocument, and contain a wide range of uncertain factors. Actual results may differ significantly from thesefigures due to factors such as changes in the business environment.

2. Quarterly Consolidated Financial Statements and Principal Notes(1) Quarterly Consolidated Balance Sheets(Thousand yen)
As of June 30, 2021
AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade
Notes and accounts receivable - trade, andcontract assets
Electronically recorded monetary claims operating
Merchandise
Other
Total current assets
Non-current assets
Property, plant and equipment
Intangible assets
Other
Total intangible assets
Investments and other assets
Total non-current assets
Total assets
Liabilities
Current liabilities
Notes and accounts payable - trade
Electronically recorded obligations - operating
Short-term borrowings
Income taxes payable
Provision for bonuses for directors (and otherofficers)
Provision for bonuses
Other
Total current liabilities
Non-current liabilities
Long-term borrowings
Provision for share awards for directors (andother officers)
Retirement benefit liability
Long-term accounts payable - other
Other
Total non-current liabilities
Total liabilities
Net assets
Shareholders' equity
Share capital
Capital surplus
Retained earnings
Treasury shares
Total shareholders' equity
Accumulated other comprehensive income
Valuation difference on available-for-salesecurities
Remeasurements of defined benefit plans
Total accumulated other comprehensive income
Non-controlling interests
Total net assets
Total liabilities and net assets

As of March 31, 2022

2,158,875
18,710,644–

2,880,571–
23,749,020

2,246,521

2,408,937

5,431,149
557,800
29,104,992

5,502,147
473,995
35,014,673

4,653,580

4,619,466

698,501
698,501
2,104,991
7,457,073
36,562,066

764,303764,303
1,978,944
7,362,714
42,377,387

16,304,571
6,824,412
520,000
524,874–

20,719,220
6,052,806
2,620,000
343,566
12,56435,2901,909,551
26,118,699

70,6291,454,678
31,273,465

275,000
155,222

110,000
201,625

398,652
279,927
1,203,040
2,311,843
28,430,543

425,897
278,127
1,199,310
2,214,961
33,488,426

607,750
346,954
7,143,982(246,635)
7,852,050

607,750
315,704
7,967,686(240,155)
8,650,985

134,964

109,014

144,507279,472–
8,131,522
36,562,066

128,960
237,975–
8,888,960
42,377,387

(2) Quarterly Consolidated Statements of Income and Comprehensive Income
Quarterly Consolidated Statements of Income
Nine Months Ended March 31

Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Operating profit
Non-operating income
Interest income
Dividend income
Insurance claim income
Commission income
Electricity sale income
Subsidy income
Share of profit of entities accounted for using
equity method
Other
Total non-operating income
Non-operating expenses
Interest expenses
Share of loss of entities accounted for using equity
methodElectricity sale expenses
Other
Total non-operating expenses
Ordinary profit
Extraordinary income
Gain on sale of property, plant and equipment
Total extraordinary income
Extraordinary losses
Loss on retirement of property, plant andequipment
Loss on sale of property, plant and equipment
Impairment losses
Total extraordinary losses
Profit before income taxes
Income taxes - currentIncome taxes - deferred
Total income taxes
ProfitProfit attributable to non-controlling interests
Profit attributable to owners of parent

For the nine months ended
March 31, 2021
77,608,405
68,734,287
8,874,117
7,517,478
1,356,639(Thousand yen)
For the nine months ended
March 31, 2022
81,756,761
72,425,239
9,331,522
7,653,139
1,678,383

264
899
2,038
24,005
6,636
–
–

185
768
7,626
15,4835,981
3,306
12,51911,04444,8894,517
50,38817,88014,297

16,621
–

4,642
3,740
40,561
1,360,967

4,286
6,161
27,0691,701,702

1,419
1,419

3,834
3,834

824

2,444––
824
1,361,561
471,830
5,975
477,805
883,756–
883,756

2,675
18,77023,8901,681,646
434,896
113,099
547,996
1,133,650–
1,133,650

Quarterly Consolidated Statements of Comprehensive Income
Nine Months Ended March 31Profit
Other comprehensive income
Valuation difference on available-for-sale securities
Remeasurements of defined benefit plans, net of tax
Total other comprehensive income
Comprehensive income
Comprehensive income attributable toComprehensive income attributable to owners of parent
Comprehensive income attributable to non-controllinginterests

For the nine months ended
March 31, 2021
883,756(Thousand yen)
For the nine months ended
March 31, 2022
1,133,650(2,735)(8,730)(11,466)
872,290(25,950)(15,546)(41,497)
1,092,153

872,290–

1,092,153–